Chang‐Yan Li
Tianjin University(CN)Kunming Medical University(CN)First Affiliated Hospital of Kunming Medical University(CN)Qinghai Tibetan Hospital(CN)Lanzhou University Second Hospital(CN)Beijing Radiation Center(CN)Beijing Proteome Research Center(CN)State Key Laboratory of ProteomicsLanzhou University(CN)
Publications by Year
Research Areas
Liver physiology and pathology, Inflammasome and immune disorders, Pancreatic function and diabetes, RNA modifications and cancer, Ubiquitin and proteasome pathways
Most-Cited Works
- → Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway(2011)307 cited
- → A new rice breeding method: CRISPR/Cas9 system editing of the Xa13 promoter to cultivate transgene‐free bacterial blight‐resistant rice(2019)155 cited
- → ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination(2019)147 cited
- → PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells(2010)97 cited
- → Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases(2021)78 cited
- → Specific Expression and Regulation of Hepassocin in the Liver and Down-regulation of the Correlation of HNF1α with Decreased Levels of Hepassocin in Human Hepatocellular Carcinoma(2009)74 cited